Threshold Pharmaceuticals Announces First Patient Dosed in Immunotherapy Clinical Trial of Evofosfamide and … – GlobeNewswire (press release)
|
Threshold Pharmaceuticals Announces First Patient Dosed in Immunotherapy Clinical Trial of Evofosfamide and …
GlobeNewswire (press release) “We believe that adding evofosfamide to certain immunotherapies has the potential to render some of the most therapeutically resistant cancers more sensitive to the immunotherapy and we are excited to have dosed the first patient in this study,” said … |
WFAA |
Oral Immunotherapy may be answer to food allergy issues
WFAA Children with food allergies used to only have one option: avoid what you’re allergic to. But thanks to food allergy research, there’s another solution. Like any mom, Christine Cassen will do anything to protect her children. Chloe is eight and Emma is … |
Nature.com |
Synthetic biology: Phagocytic protocells
Nature.com A synthetic colloidal system has been developed that mimics the biological process of phagocytosis — the ingestion of foreign material by certain cell types. As Stephen Mann and colleagues report in Nature Materials, synthetic ‘ecosystems’ such as … |
South China Morning Post |
Hong Kong biotech start-up claims world first in stem cell treatment of Alzheimer’s and Parkinson’s diseases
South China Morning Post But Yung claims his team is the first to successfully harvest stem cells directly from the brain and re-inject the developed neural cells back into a live subject, thereby artificially regenerating any cells which have died off, due to neurological … |
IMTJ |
The world’s first stem cell healthcare insurance plan
IMTJ Subsidiary CellPlan has developed the world’s first stem cell healthcare insurance plan and medical concierge service. The company has also developed a new commercial CellPlan medical opinion product- Your Expert Consultation that provides clients with … |
|
Engineering nature to prevent disease signals potential of synthetic biology
The Straits Times He is one of the 100 experts speaking at the Seventh International Meeting on Synthetic Biology, which opens on Tuesday (June 13). The event is co-organised by the National University of Singapore’s Synthetic Biology for Clinical and Technological … |